ISARIC's purpose is to prevent illness and deaths from infectious disease outbreaks. We are a global federation of clinical research networks, providing a proficient, coordinated, and agile research response to outbreak-prone infectious diseases.
The results in this report have been produced using data from the ISARIC COVID-19 database. We welcome additional partners to collaborate in this effort. Please contact ncov@isaric.org.
Link to: Latest report
Thank you to our frontline colleagues who selflessly continue to contribute data to better understand COVID-19, to improve patient care, and to inform policy & planning.
To determine whether hydrocortisone improves outcome for patients with severe COVID-19. An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or ...
Very little is known about possible clinical sequelae that may persist after resolution of the acute Coronavirus Disease 2019 (COVID-19). A recent longitudinal cohort from Italy including 143 patients recovered ...
Bubonic plague is the primary manifestation of infection with Y. pestis, accounting for 90% of all plague cases, and with 75% of global cases reported in Madagascar. All drugs ...
Major infectious disease outbreaks are a constant threat to human health. Clinical research responses to outbreaks generate evidence to improve outcomes and outbreak control. Experiences from previous epidemics have identified ...
The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), based at Oxford University, in collaboration with Dr Janet Scott, of the MRC-University of Glasgow’s Centre for Virus Research, has launched a longitudinal observational study to measure prevalence and risk ... Read more
Researchers and clinicians in Glasgow will lead a global study into the long-term health impacts of COVID-19. The international, multi-site study is launched by ISARIC to measure prevalence and risk factors of long-term health and psychosocial consequences of COVID-19. The ... Read more
Even as the COVID-19 pandemic enters into its ninth month, much remains unknown about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 disease. One such area is the possible long-term consequences of SARS-CoV-2 infection and the risk factors ... Read more